NL192604C - Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. - Google Patents
Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. Download PDFInfo
- Publication number
- NL192604C NL192604C NL8901840A NL8901840A NL192604C NL 192604 C NL192604 C NL 192604C NL 8901840 A NL8901840 A NL 8901840A NL 8901840 A NL8901840 A NL 8901840A NL 192604 C NL192604 C NL 192604C
- Authority
- NL
- Netherlands
- Prior art keywords
- ranitidine
- bismuth
- solution
- salt
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8817098 | 1988-07-18 | ||
GB888817098A GB8817098D0 (en) | 1988-07-18 | 1988-07-18 | Chemical compounds |
GB898904686A GB8904686D0 (en) | 1989-03-01 | 1989-03-01 | Chemical compounds |
GB8904686 | 1989-03-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8901840A NL8901840A (nl) | 1990-02-16 |
NL192604B NL192604B (nl) | 1997-07-01 |
NL192604C true NL192604C (nl) | 1997-11-04 |
Family
ID=26294175
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8901840A NL192604C (nl) | 1988-07-18 | 1989-07-17 | Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. |
NL970046C NL970046I2 (nl) | 1988-07-18 | 1997-12-18 | Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL970046C NL970046I2 (nl) | 1988-07-18 | 1997-12-18 | Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. |
Country Status (35)
Country | Link |
---|---|
US (1) | US5008256A (ja) |
JP (1) | JP2523185B2 (ja) |
KR (1) | KR0122598B1 (ja) |
CN (1) | CN1022626C (ja) |
AT (1) | AT398200B (ja) |
AU (1) | AU632052B2 (ja) |
BE (1) | BE1003254A5 (ja) |
CA (1) | CA1332610C (ja) |
CH (1) | CH679582A5 (ja) |
CY (1) | CY1650A (ja) |
DE (1) | DE3923638C2 (ja) |
DK (1) | DK168381B1 (ja) |
EG (1) | EG19368A (ja) |
ES (1) | ES2014175A6 (ja) |
FI (1) | FI90538C (ja) |
FR (1) | FR2634122B1 (ja) |
GB (1) | GB2220937B (ja) |
GR (1) | GR1000431B (ja) |
HK (1) | HK61392A (ja) |
HU (2) | HU206104B (ja) |
IE (1) | IE61076B1 (ja) |
IL (1) | IL91005A (ja) |
IT (1) | IT1231481B (ja) |
LU (2) | LU88722I2 (ja) |
MX (1) | MX174145B (ja) |
MY (1) | MY104055A (ja) |
NL (2) | NL192604C (ja) |
NO (2) | NO176319C (ja) |
NZ (1) | NZ229958A (ja) |
PL (1) | PL162391B1 (ja) |
PT (1) | PT91188B (ja) |
SE (1) | SE468715B (ja) |
SG (1) | SG51992G (ja) |
YU (1) | YU47021B (ja) |
ZW (1) | ZW8689A1 (ja) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
EP0282132B1 (en) * | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Compositions and their use for treating gastrointestinal disorders |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
GB9009240D0 (en) * | 1990-04-25 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
AU648574B2 (en) * | 1990-07-20 | 1994-04-28 | Tillotts Pharma Ag | Products and processes for the treatment of the alimentary canal |
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
DE69228738D1 (de) * | 1991-12-06 | 1999-04-29 | Glaxo Group Ltd | Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten |
WO1996019232A1 (en) * | 1994-12-19 | 1996-06-27 | Lauteral Limited | Combinations of ranitidine hydrochloride-form 1 and bismuth compounds |
EP0805815B1 (en) * | 1995-01-26 | 2002-04-10 | Nycomed Imaging A/S | Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori |
GB9501560D0 (en) * | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
EP1035192A1 (de) * | 1999-01-26 | 2000-09-13 | Stefan Graichen | Additiv für einen Kühlschmierstoff |
CN1102585C (zh) * | 1999-04-28 | 2003-03-05 | 常州兰陵制药有限公司 | 雷尼替丁枸橼酸铋盐的制备方法 |
US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
CN100402514C (zh) * | 2006-08-01 | 2008-07-16 | 丽珠医药集团股份有限公司 | 一种制备枸橼酸铋雷尼替丁的方法 |
WO2009008895A1 (en) * | 2007-07-09 | 2009-01-15 | Cypress Pharmaceutical, Inc. | Pleasant-tasting ranitidine formulation |
CN102408398B (zh) * | 2011-09-20 | 2012-12-05 | 江苏汉斯通药业有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
US9731999B2 (en) | 2011-09-23 | 2017-08-15 | Iqbal Gill | Chemical admixtures for hydraulic cements |
ES2426539B1 (es) * | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
CN103896888B (zh) * | 2014-03-28 | 2015-11-18 | 常州兰陵制药有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
EP2929884A1 (en) | 2014-04-11 | 2015-10-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and h2-receptor antagonists |
EP2942058A1 (en) | 2014-05-09 | 2015-11-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists |
CN107382921A (zh) * | 2017-07-28 | 2017-11-24 | 常州兰陵制药有限公司 | 制备枸橼酸铋雷尼替丁的方法 |
EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
FR2531706A1 (fr) * | 1982-08-13 | 1984-02-17 | Sanofi Sa | Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant |
BE905235A (fr) * | 1986-08-05 | 1986-12-01 | Hasunor Ag | Ascorbates antagonistes des recepteurs h2 et leur procede de preparation. |
IT1215325B (it) * | 1987-01-07 | 1990-02-08 | Barisintex Sa | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
EP0282132B1 (en) * | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Compositions and their use for treating gastrointestinal disorders |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
DE3710462A1 (de) * | 1987-03-30 | 1988-10-13 | Heumann Pharma Gmbh & Co | Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
-
1989
- 1989-07-14 CH CH2647/89A patent/CH679582A5/fr not_active IP Right Cessation
- 1989-07-17 AT AT0172889A patent/AT398200B/de not_active IP Right Cessation
- 1989-07-17 CN CN89104959A patent/CN1022626C/zh not_active Expired - Fee Related
- 1989-07-17 LU LU88722C patent/LU88722I2/fr unknown
- 1989-07-17 NO NO892936A patent/NO176319C/no not_active IP Right Cessation
- 1989-07-17 YU YU142789A patent/YU47021B/sh unknown
- 1989-07-17 US US07/380,378 patent/US5008256A/en not_active Expired - Lifetime
- 1989-07-17 DK DK351789A patent/DK168381B1/da not_active IP Right Cessation
- 1989-07-17 JP JP1184402A patent/JP2523185B2/ja not_active Expired - Lifetime
- 1989-07-17 GR GR890100454A patent/GR1000431B/el not_active IP Right Cessation
- 1989-07-17 FR FR8909575A patent/FR2634122B1/fr not_active Expired - Fee Related
- 1989-07-17 NZ NZ229958A patent/NZ229958A/xx unknown
- 1989-07-17 ES ES8902517A patent/ES2014175A6/es not_active Expired - Fee Related
- 1989-07-17 PL PL28062889A patent/PL162391B1/pl unknown
- 1989-07-17 GB GB8916288A patent/GB2220937B/en not_active Expired - Lifetime
- 1989-07-17 PT PT91188A patent/PT91188B/pt not_active IP Right Cessation
- 1989-07-17 AU AU38178/89A patent/AU632052B2/en not_active Ceased
- 1989-07-17 SE SE8902550A patent/SE468715B/sv not_active IP Right Cessation
- 1989-07-17 MX MX1682989A patent/MX174145B/es unknown
- 1989-07-17 CA CA000605843A patent/CA1332610C/en not_active Expired - Fee Related
- 1989-07-17 IT IT8948196A patent/IT1231481B/it active Protection Beyond IP Right Term
- 1989-07-17 DE DE3923638A patent/DE3923638C2/de not_active Expired - Fee Related
- 1989-07-17 NL NL8901840A patent/NL192604C/nl not_active IP Right Cessation
- 1989-07-17 IL IL9100589A patent/IL91005A/en not_active IP Right Cessation
- 1989-07-17 EG EG34289A patent/EG19368A/xx active
- 1989-07-17 IE IE230989A patent/IE61076B1/en not_active IP Right Cessation
- 1989-07-17 HU HU893595A patent/HU206104B/hu unknown
- 1989-07-17 MY MYPI89000969A patent/MY104055A/en unknown
- 1989-07-17 BE BE8900773A patent/BE1003254A5/fr not_active IP Right Cessation
- 1989-07-17 ZW ZW86/89A patent/ZW8689A1/xx unknown
- 1989-07-17 FI FI893448A patent/FI90538C/fi not_active IP Right Cessation
- 1989-07-17 LU LU87557A patent/LU87557A1/fr active Protection Beyond IP Right Term
- 1989-07-18 KR KR1019890010213A patent/KR0122598B1/ko not_active IP Right Cessation
-
1992
- 1992-05-09 SG SG519/92A patent/SG51992G/en unknown
- 1992-08-13 HK HK613/92A patent/HK61392A/xx not_active IP Right Cessation
- 1992-12-11 CY CY1650A patent/CY1650A/xx unknown
-
1995
- 1995-06-12 HU HU95P/P00186P patent/HU211173A9/hu unknown
-
1997
- 1997-12-18 NL NL970046C patent/NL970046I2/nl unknown
-
1998
- 1998-02-05 NO NO1998007C patent/NO1998007I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL192604C (nl) | Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. | |
KR101226669B1 (ko) | N,n-디메틸 이미도디카르본이미딕 디아미드의 디카르복실산염, 그의 제조 방법 및 그의 약제학적 조성물 | |
SA99200064B1 (ar) | مشتقات إيميدازو بيريدين imidazo pyridine المثبطة لإفراز الحمض المعدي acid secretion | |
DE69108913T2 (de) | 4-alkylimidazolderivate. | |
JP2915021B2 (ja) | カルボン酸誘導体 | |
JPH04217676A (ja) | カルボン酸誘導体 | |
JPS6126996B2 (ja) | ||
JPH05117259A (ja) | カルボン酸誘導体 | |
KR101688238B1 (ko) | 리코펠론의 콜린 및 트로메타민 염 | |
RU2114857C1 (ru) | Соли, образованные ранитидином и комплексным соединением висмута с карбоновой кислотой, и фармацевтический препарат | |
CN103601673B (zh) | 3-羟基吡啶-4-酮的氟化衍生物 | |
CN112839934B (zh) | 一种沃诺拉赞盐及其制备方法与用途 | |
SI8911427A (sl) | Postopek za pripravo soli ranitidina z bizmutovimi kompleksi karboksilnih kislin | |
WO2022011752A1 (zh) | 一种沃诺拉赞盐及其制备方法与用途 | |
CZ285821B6 (cs) | Sůl tvořená ranitidinem a komlexem vizmutu s karboxylovou kyselinou, farmaceutický prostředek s obsahem této soli a způsob přípravy uvedené soli | |
JPS60163930A (ja) | ポリシルセスキオキサン | |
JPH0688974B2 (ja) | 2−ピリジルアセタミド誘導体、その製法および用途 | |
JPH01501387A (ja) | 2―メチルメルカプト―3―シアノ―4―(0―ジフルオロメトキシフェニル)―6―フェニル―1,4―ジヒドロピリジン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
AC1 | Application for a supplementary protection certificate |
Free format text: 970046, 971218 |
|
KC1 | Grant of a supplementary protection certificate |
Free format text: 970046, 20090717, EXPIRES: 20100713 |
|
V1 | Lapsed because of non-payment of the annual fee |
Effective date: 20070201 |